• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVE DIVISION CONTEGRA; CONDUIT,VALVED,PULMONIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVE DIVISION CONTEGRA; CONDUIT,VALVED,PULMONIC Back to Search Results
Model Number 200H14
Device Problems Calcified (1077); Insufficient Information (3190)
Patient Problems Pulmonary Valve Stenosis (2024); No Information (3190)
Event Date 10/29/2019
Event Type  Injury  
Manufacturer Narrative
Product analysis: no product was returned.Conclusion: without the return of the product, no definitive conclusion can be made regarding the clinical observation.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information that 2 years and 4 months post implant of this 14mm pulmonary valved conduit in an (b)(6)-month-old pediatric patient, it was explanted and replaced with an 18mm pulmonary valved conduit of the same model.The reason for replacement was not reported.No additional adverse patient effects were reported.
 
Manufacturer Narrative
Medtronic received additional information.It was reported that the pulmonary valved conduit was severely calcified, particularly at the proximal and distal anastomosis sites.As a result, the conduit was severely stenotic.Concomitant with the conduit replacement, the patient's left and right pulmonary artery branches were augmented with a patch.This was performed due to stenosis, reported to be a result of scar tissue and calcification surrounding the conduit anastomosis.Additionally, it was reported that the proximal right ventricular outflow tract (rvot) was obstructed, but below the level of the conduit.It was reported that this obstruction was muscular in nature.As a result, a portion of the rvot muscle bundle was resected.The patient tolerated the procedure well, and no additional adverse patient effects were reported.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONTEGRA
Type of Device
CONDUIT,VALVED,PULMONIC
Manufacturer (Section D)
MEDTRONIC HEART VALVE DIVISION
1851 e deere ave
santa ana CA 92705
MDR Report Key9394799
MDR Text Key168598059
Report Number2025587-2019-03625
Device Sequence Number1
Product Code MWH
Combination Product (y/n)N
PMA/PMN Number
H020003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 02/19/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number200H14
Device Catalogue Number200H14
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 11/07/2019
Initial Date FDA Received12/02/2019
Supplement Dates Manufacturer Received02/19/2020
Supplement Dates FDA Received02/19/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age36 MO
-
-